ECG vs ACA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ECG

38.6
AI Score
VS
ACA Wins

ACA

52.2
AI Score

Investment Advisor Scores

ECG

39score
Recommendation
AVOID NEW MONEY

ACA

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ECG ACA Winner
Forward P/E 19.2308 29.8507 ECG
PEG Ratio 0 1.8642 Tie
Revenue Growth 33.7% 1.7% ECG
Earnings Growth 59.2% 448.6% ACA
Tradestie Score 38.6/100 52.2/100 ACA
Profit Margin 6.0% 16.8% ACA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ACA

Relative Price Performance (Last 90 Days)

ECG 1M: +10.9% · 3M: -13.1% ACA 1M: +0.9% · 3M: +1.0%

Current Technical Phase

ECG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $125.02

ACA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.9 · Price: $146.78

Fundamentals Snapshot

Metric ECG ACA
Market Cap — —
Forward P/E 19.9 28.6
Trailing P/E 23.6 32.6
Revenue (TTM) — —
Revenue Growth 0.3% 0.0%
Gross Margin 0.1% 0.2%
Operating Margin 0.1% 0.1%
EPS 4.98 4.48
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.